A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition
Abstract Background Paracetamol/Orphenadrine is a fixed dose combination containing 35 mg orphenadrine and 450 mg paracetamol. It has analgesic and muscle relaxant properties and is widely available as generics. This study is conducted to investigate the relative bioavailability and bioequivalence b...
Main Authors: | Kit Yee Cheah, Kar Yee Mah, Lai Hui Pang, Shi Min Ng, Jia Woei Wong, Siew Siew Tan, Hong Zhe Tan, Kah Hay Yuen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40360-020-00416-3 |
Similar Items
-
Evaluation of the advantages of orphenadrine in anaesthesia caused by ketamine in mice
by: Ahmed S. Naser, et al.
Published: (2024-01-01) -
Detection of potential effects of orphenadrine upon anesthesia with propofol and/or thiopental in mice
by: Yasser M. Albadrany, et al.
Published: (2024-01-01) -
Simultaneous determination of tramadol and paracetamol in human plasma using LC-MS/MS and application in bioequivalence study of fixed-dose combination
by: Gabriel Onn Kit Loh, et al.
Published: (2023-12-01) -
Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery
by: A.B. Barroso, et al.
Published: (2006-09-01) -
Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery
by: A.B. Barroso, et al.